Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery

F Tang, L Li, D Chen - Advanced materials, 2012 - Wiley Online Library
In the past decade, mesoporous silica nanoparticles (MSNs) have attracted more and more
attention for their potential biomedical applications. With their tailored mesoporous structure …

Mesoporous silica nanoparticles in biomedical applications

Z Li, JC Barnes, A Bosoy, JF Stoddart… - Chemical Society …, 2012 - pubs.rsc.org
This tutorial review provides an outlook on nanomaterials that are currently being used for
theranostic purposes, with a special focus on mesoporous silica nanoparticle (MSNP) based …

Dextran-coated iron oxide nanoparticles as biomimetic catalysts for localized and pH-activated biofilm disruption

PC Naha, Y Liu, G Hwang, Y Huang, S Gubara… - ACS …, 2019 - ACS Publications
Biofilms are surface-attached bacterial communities embedded within an extracellular matrix
that create localized and protected microenvironments. Acidogenic oral biofilms can …

Nanoparticle PEGylation for imaging and therapy

JV Jokerst, T Lobovkina, RN Zare, SS Gambhir - Nanomedicine, 2011 - Taylor & Francis
Nanoparticles are an essential component in the emerging field of nanomedical imaging
and therapy. When deployed in vivo, these materials are typically protected from the immune …

Chemical basis of interactions between engineered nanoparticles and biological systems

Q Mu, G Jiang, L Chen, H Zhou, D Fourches… - Chemical …, 2014 - ACS Publications
As defined by the European Commission, a nanomaterial is a natural, an incidental, or a
manufactured material containing particles in an unbound state or as an aggregate or …

Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice

H Meng, M Wang, H Liu, X Liu, A Situ, B Wu, Z Ji… - ACS …, 2015 - ACS Publications
Recently, a commercial albumin-bound paclitaxel (PTX) nanocarrier (Abraxane) was
approved as the first new drug for pancreatic ductal adenocarcinoma in almost a decade …

Mesoporous silica nanoparticles: synthesis, pharmaceutical applications, biodistribution, and biosafety assessment

F Farjadian, A Roointan, S Mohammadi-Samani… - Chemical Engineering …, 2019 - Elsevier
Mesoporous silica nanoparticles (MSNs) are a key example of the innovation in material
science to develop nanotechnology-based delivery systems. Biological and pharmaceutical …

Multifunctional mesoporous silica nanoparticles for biomedical applications

B Xu, S Li, R Shi, H Liu - Signal Transduction and Targeted Therapy, 2023 - nature.com
Mesoporous silica nanoparticles (MSNs) are recognized as a prime example of
nanotechnology applied in the biomedical field, due to their easily tunable structure and …

The effect of nanoparticle size, shape, and surface chemistry on biological systems

A Albanese, PS Tang, WCW Chan - Annual review of biomedical …, 2012 - annualreviews.org
An understanding of the interactions between nanoparticles and biological systems is of
significant interest. Studies aimed at correlating the properties of nanomaterials such as …

Mesoporous silica nanoparticles for intracellular controlled drug delivery

JL Vivero‐Escoto, II Slowing, BG Trewyn, VSY Lin - Small, 2010 - Wiley Online Library
The application of nanotechnology in the field of drug delivery has attracted much attention
in the latest decades. Recent breakthroughs on the morphology control and surface …